BIOLINE RX LIMITED
Q4 2025 13F Holders
Symbol
BLRX
CUSIP
09071M304
Type
Equity
Class
SPONSORED ADR
Num filings
16
Total reported value, excl. options
$136 k
Compare 2025 Q4 to
2026 Q2
2026 Q1
2025 Q3
2025 Q2
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type